Endogenously expressed estrogen receptors mediate neuroprotection in hippocampal cells (HT22).
Discovery of estrogen receptors (ER) in the central nervous system and the ability of estrogens to modulate neural circuitry and act as neurotrophic factors, suggest a therapeutic role of this steroid. To gain better understanding of the specificity and cellular mechanisms involved in estrogen-mediated neuroprotection, a mouse hippocampal neuronal cell line (HT22) was evaluated. Earlier reports indicated this cell line was devoid of ERs. Contrary to these findings, characterization of HT22 cells using RT-PCR, immunoblot, immunocytochemical, and radioligand binding techniques revealed endogenous expression of ER. The predominant subtype appeared to be ERalpha with functional activity confirmed using an ERE-tk-luciferase assay. The ability of an ER antagonist, ICI-182780, to block the neuroprotective effects of estrogens confirmed ER was involved mechanistically in neuroprotection. In conclusion, HT22 cells express functional ERalpha or a closely related ER enabling this cell line to be used to profile estrogens for neuroprotective properties acting via an ER-dependent mechanism.
Deecher
Darlene C
DC
Women's Health Research Institute, Wyeth Research, Collegeville, Pennsylvania 19426, USA. deeched@wyeth.com
Daoud
Pamela
P
Bhat
Ramesh A
RA
O'Connor
Lawrence T
LT
D000818:Animals; D002460:Cell Line; D017931:DNA Primers; D004967:Estrogens / Q000502:physiology; D018698:Glutamic Acid / Q000633:toxicity; D006624:Hippocampus / Q000166:cytology*; D007150:Immunohistochemistry; D051379:Mice; D018696:Neuroprotective Agents; D011869:Radioligand Assay; D011960:Receptors, Estrogen / Q000502:physiology*; D020133:Reverse Transcriptase Polymerase Chain Reaction
D017931:DNA Primers; D004967:Estrogens; D018696:Neuroprotective Agents; D011960:Receptors, Estrogen; D018698:Glutamic Acid